Achillion Pharmaceuticals, Inc. (ACHN) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts ACHN Hot Sheet
Join SI Premium – FREE
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) reported Q2 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Achillion Pharmaceuticals, Inc. (ACHN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
- RenovoRx regains Nasdaq minimum bid price compliance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
